Health care costs

FILE- In this July 10, 2018, file photo bottles of medicine ride on a belt at a mail-in pharmacy warehouse in Florence, N.J. Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. (AP Photo/Julio Cortez, File)
August 19, 2019 - 4:41 pm
TRENTON, N.J. (AP) — Drug companies are still raising prices for brand-name prescription medicines, just not as often or by as much as they used to, according to an Associated Press analysis. After years of frequent list price hikes, many drugmakers are showing some restraint, according to the...
Read More
FILE - In this Wednesday, July 10, 2019, file photo, President Donald Trump speaks about kidney health, accompanied by Health and Human Services Secretary Alex Azar, left, in Washington. Azar says he and Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada. (AP Photo/Alex Brandon, File)
July 31, 2019 - 3:19 pm
WASHINGTON (AP) — The Trump administration said Wednesday it will create a way for Americans to legally and safely import lower-cost prescription drugs from Canada for the first time, reversing years of refusals by health authorities amid a public outcry over high prices for life-sustaining...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. Merck & Co., Inc. reports financial results on Tuesday, July 30, 2019. (AP Photo/Seth Wenig, File)
July 30, 2019 - 2:31 pm
Soaring sales of its cancer blockbuster and vaccines helped drive Merck's second-quarter profit up a whopping 54%, blowing past Wall Street expectations. The maker of cancer immunotherapy drug Keytruda and diabetes pill Januvia also benefited from slightly reduced spending on research and...
Read More
FILE - In this Jan. 28, 2019, file photo, Bonnie Bowman, a supporter of a voter-approved measure to fully expand Medicaid, gathers with others during a rally at the Utah state Capitol, urging lawmakers not to change the law. President Donald Trump's administration has rejected Utah's planned request for enhanced federal funding for partial expansion of its Medicaid program, state officials said Saturday, July 27. (AP Photo/Rick Bowmer, File)
July 29, 2019 - 6:17 pm
SALT LAKE CITY (AP) — The Trump administration's rejection of Utah's plan to partially expand Medicaid could send other states back to the drawing board on covering more low-income people under President Barack Obama's signature health care law. The decision is disappointing for leaders in...
Read More
FILE - In this Sept. 21, 2016, file photo EpiPens that Mylan CEO Heather Bresch bought with her are seen on Capitol Hill in Washington as she testifies before the House Oversight Committee hearing on EpiPen price increases. Pfizer, the country's largest drugmaker, will absorb the generic pharmaceutical company Mylan, potentially creating a global generic powerhouse, the two companies said Monday, July 29, 2019. (AP Photo/Pablo Martinez Monsivais, File)
July 29, 2019 - 5:48 pm
Pfizer, the country's largest drugmaker, is creating a hybrid new drug company by combining its off-patent branded drug business with the generic pharmaceutical company Mylan. Pfizer's Upjohn, which sells one-time blockbusters like Viagra and Lipitor that have lost patent protection, will be spun...
Read More
FILE - In this July 8, 2016, file photo, a prescription is filled at Pucci's Pharmacy in Sacramento, Calif. Four pharmaceutical companies are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high. California Attorney General Xavier Becerra said Monday, July 29, 2019, that the bulk of the money will come from Teva Pharmaceutical Industries for paying to delay a generic narcolepsy drug from entering the market for nearly six years. (AP Photo/Rich Pedroncelli, File)
July 29, 2019 - 4:26 pm
SACRAMENTO, Calif. (AP) — Four pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday. The bulk of the money will come from Teva Pharmaceutical...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. A prescription drug compromise that would lower costs for Medicare recipients has cleared a key hurdle in the Senate, but Republican resistance signals trouble when the legislation goes to the floor. (AP Photo/Elise Amendola, File)
July 25, 2019 - 8:15 pm
WASHINGTON (AP) — A prescription drug compromise that would lower costs for Medicare recipients and save billions for Medicare and Medicaid cleared a key hurdle in the Senate on Thursday, but Republican resistance signaled trouble as the legislation faces floor consideration. The Finance Committee...
Read More
House Speaker Nancy Pelosi of Calif. and House Democrats arrive for a news conference on the first 200 days of the 116th Congress at the House east front steps on Capitol Hill, in Washington, Thursday, July 25, 2019. (AP Photo/Andrew Harnik)
July 25, 2019 - 12:30 pm
WASHINGTON (AP) — Congressional Democrats on Thursday pivoted away from questions of impeachment by saying they are going to "own" the upcoming August recess on issues like health care and prescription drug costs. Not emphasized was the testimony a day earlier by former special counsel Robert...
Read More
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. Two senior senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs that serve seniors and low-income people. (AP Photo/Elise Amendola)
July 23, 2019 - 7:19 pm
WASHINGTON (AP) — Two veteran senators — a Republican and a Democrat — unveiled compromise legislation Tuesday to reduce prescription drug costs for millions of Medicare recipients, while saving money for federal and state health care programs serving seniors and low-income people. Iowa Republican...
Read More
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington. (AP Photo/Alex Brandon)
July 11, 2019 - 10:33 am
WASHINGTON (AP) — President Donald Trump is withdrawing a plan to ease the financial bite of costly medications for people on Medicare by letting them to receive rebates that drugmakers now pay to insurers and middlemen, the White House said Thursday. The once-highly promoted plan from Health and...
Read More

Pages